Macular Hole — Idiopathic Foveal Defect
Simulate idiopathic macular hole (MH) — a full-thickness defect in the central fovea
caused by tangential vitreous traction on the foveola, producing a characteristic
central scotoma, metamorphopsia (distortion), and sudden reduction in central visual
acuity. Macular holes are classified by the four-stage Gass system (revised 1995):
Stage 1 (impending hole — foveal pseudocyst / yellow foveal spot or ring from
tangential vitreous traction without full-thickness loss), Stage 2 (small full-thickness
hole, <400 µm, with vitreous attachment, bridging pseudo-operculum),
Stage 3 (full-thickness hole, >400 µm, with visible operculum, vitreous
still attached to the opercular fragment — greatest risk of visual loss from
outer foveal cone degeneration), and Stage 4 (full-thickness hole of any
size with complete posterior vitreous detachment [PVD] confirmed by
Weiss ring on the detached posterior hyaloid). Macular holes affect
approximately 3 per 1,000 adults over age 55, with a strong female
predominance (female:male ratio approximately 3:1). Pars plana
vitrectomy (PPV) with internal limiting membrane (ILM) peeling under
chromovitrectomy (using vital dyes such as membrane blue, triamcinolone,
or brilliant blue G) and gas tamponade (SF6 or C3F8) achieves hole closure
in 80–95% of cases with visual acuity recovery to 6/12 or better in most
patients with Stage 2–3 holes of short duration. Model three clinical stages:
Stage 1-2 impending/small hole (foveal pseudocyst and small full-thickness defect),
Stage 3 full-thickness hole with operculum (active vitreous traction),
and Stage 4 large hole with complete PVD (maximal central visual loss).
Inspect central scotoma-induced ΔE colour shift, CIE xy chromaticity,
and image-level simulation of foveal defect visual distortion.
Macular hole colour science simulation by Auric Artisan.